Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
M. Suzuki, S. Okamura, T. Gis, H. Sasaki, S. Lee, A. Yoshida, S. Goto, M. Matsumoto, M. Yamawaki, T. Miyazaki, T. Nakagawa, M. Ikawa, W. Kamitani, S. Takekawa, K. Yamanishi, H. Ebina
This study develops a live-attenuated SARS-CoV-2 vaccine candidate, BK2102, which induces long-term immunity and is safe in animal models.
bioRxiv · Mar 3, 2024Microbiology